Imiphumo emibi ye-Adderall kwi-ADHD

NjengoRitalin, i-Adderall iyakhuthaza, kodwa kunokuba yenziwe nge-methylphenidate, i-Adderall ngumxube wee-amphetamine. Inokukunceda ukunciphisa okanye ukuphucula iimpawu ze-ADHD, kubandakanywa nokunakekelwa okufutshane kunye / okanye ukunyanzeliswa kunye nokungachukumisi.

I-Adderall yinkqubela emfutshane kwaye idla ngokuphindwe kabini ngosuku.

I-Adderall XR yindlela ebenzela ixesha elide le-stimulant enokunikezwa kanye kanye ngosuku ukwenzela ukuba abantwana bangathathi isidlo sasemini.

Ngokuqhelekileyo ihlala iiyure ezili-10-12 kubantwana abaninzi.

Isistim

Njengokuba kunjalo nezinye izikhuthazo, ifilosofi eqhelekileyo kukuqala ngesilinganisi esisezantsi kwaye usebenze ngendlela ephakamileyo njengoko kufuneka, nokuba yinto isebenza kakuhle okanye umntwana unemiphumo emibi.

Ngokubanzi, umlinganiselo we-Adderall u malunga ne-1/2 ye-methylphenidate (Ritalin) eneemveliso, ngoko-20mg kaRitalin yayiza kuba malunga ne-10mg ye-Adderall.

I-Adderall ivunyelwe ukusetyenziswa kwabantwana abangaphezu kweminyaka engama-3. Ngokuqhelekileyo iqalwe kwi dose ye-2.5mg kwabantwana abangaphantsi kweminyaka emi-5 kwaye ngokunyuka kwanda njengoko kuyimfuneko. Abantwana abakhulileyo bavame ukuqala nge-5mg dose. Ezi ipilisi ezifunwe kabini zifumaneka ngobukhulu be-5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg, 25mg kunye no-30mg.

I-Adderall XR (ukukhululwa okwandisiweyo) ivunyiwe kubantwana abangaphezulu kweminyaka yobudala engama-6 kwaye iyafumaneka njengenye ye-capsule yosuku. Itholakala ngobukhulu be-5mg, i-10mg, i-15mg, i-20mg, i-25mg ne-30mg.

Ukuguqula ukusuka kwi-Adderall ukuya ku-Adderall XR

Kuba abantwana bajika ukusuka kwi-Adderall rhoqo kwi-Adderall XR, ngokuqhelekileyo udibanisa i-dosage abayithatha ngayo yonke imini kwaye yiyona dose eyodwa ye-Adderall XR. Ngoko abantwana abathatha i-10mg ye-Adderall kabini ngosuku babeza kuthatha i-Adderall XR 20mg ekuseni.

Imiphumela

Nangona ngokuqhelekileyo ukunyamezelwa, iziphumo eziphambili ze-Adderall kunye ne-Adderall XR ziquka:

Ukuhlangabezana Neempembelelo Zecala

Abantwana abaninzi banemiphumo emibi, kwaye ezinye zazo zingaphucula ngexesha.

Ukuba iimpembelelo ezingasayi kuphucula kunye nexesha, isidumbu sakho sezilwanyana kufuneka sinciphise umyinge womntwana wakho okanye sicinge ngokutshintsha kwenye iyeza, ezifana neVivse, i-Concerta okanye iStrattera .

Ukungqinelana

Akufanele uthathe i-Adderall ukuba unesifo senhliziyo okanye ezinye iingxaki zentliziyo, kuquka ukunyuswa kwengcinezelo yegazi, kunye neentliziyo okanye isifo sesitya segazi, i-thyroid engapheliyo, i-glaucoma okanye imbali yokusetyenziswa kakubi kweziyobisi.

Ukuba iimpembelelo ezingasayi kuphucula kunye nexesha, isidumbu sakho sezilwanyana kufuneka sinciphise umyinge womntwana wakho okanye uthathe ukutshintsha kwenye iyeza ze-ADHD, ezifana neVivse, i-Concerta, okanye i-Strattera.

I-FDA iqhuba izifundo eziqhubekayo ukujongana nezikhonkwane ezinokwenzeka phakathi kwe-Adderall kunye nezinye izikhuthazo kunye nokwanda kokufa ngokukhawuleza, ingakumbi kubantwana abaneengxaki zeentliziyo ezingenanto.

Ilumkiso lokugqibela malunga nokusetyenziswa kakubi kwe-Adderall. Ukuba umntwana wakho usebenzisa i-Adderall, kubalulekile ukubeka esweni ukusetyenziswa kwakhe. Kuqhelekileyo ngoku esikolweni esiphakamileyo (nakwesikolo esiphakathi) ukuba abantwana "babelane" nge-Adderall kunye neontanga zabo, kwaye abantwana abaninzi baye babanjiswa ukuthengisa iipilisi zabo ngokunjalo. Ekubeni i-Adderall iqhutywe kwisikolo esiphakeme kunye nesihlwele sekholeji njengengqondo "yokuphuculwa kwengqondo" abantwana abanokunyanzelisa umntwana wakho akufanele kube yinto efanayo na oya kulindeleka ukuba ubandakanyeke ekuthengeni nasekuthengiseni iziyobisi.

Imithombo:

US Food and Drug Administration. UNxibelelwano malunga nokuHlola koKhuselo oluqhubekayo lweMithi ekhuthazayo esetyenziswe kwi-Children ene-Attention-Deficit / Hyperactivity Disorder (ADHD). 08/15/13. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm165858.htm.